EA
GILD icon

Everpar Advisors’s Gilead Sciences GILD Stock Holding History

Everpar Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$567K Sell
4,488
-374
-8% -$49.3K 0.16% 132
2026
Q1 		$678K Buy
4,862
+475
+11% +$66.5K 0.23% 89
2025
Q4 		$538K Buy
4,387
+934
+27% +$114K 0.2% 113
2025
Q3 		$383K Buy
3,453
+441
+15% +$50.1K 0.15% 158
2025
Q2 		$334K Buy
+3,012
New +$321K 0.15% 182

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Everpar Advisors's GILD Position: Q2 2026 in Review

Everpar Advisors reduced its Gilead Sciences (GILD) stake by 7.7% in Q2 2026, selling an estimated $49.3K and leaving 4,488 shares worth $567K. The position accounts for 0.16% of the portfolio, ranked #132.

Everpar Advisors first reported a position in GILD in Q2 2025 and has held it in 5 quarters since. The position peaked at $678K in Q1 2026. 361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Everpar Advisors held 4,488 shares of Gilead Sciences worth $567K as of Q2 2026.
  • Everpar Advisors sold 374 Gilead Sciences shares in Q2 2026, an estimated $49.3K.
  • Gilead Sciences made up 0.16% of Everpar Advisors's portfolio in Q2 2026, its #132 holding.
  • Everpar Advisors first reported a position in Gilead Sciences in Q2 2025 and has held it in 5 quarters since.
  • Everpar Advisors's Gilead Sciences position peaked at $678K in Q1 2026.
  • 361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Everpar Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.